This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified vaccines and biological substances
VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
265 |
4. Check minimum number of eventsNone |
265 |
5. Include endpointsNone |
265 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y[4-5]
Similar endpoints
↥List of similar endpoints to
Other and unspecified vaccines and biological substances
based on the number of shared cases.
Similar with more cases:
- Drugs, medicaments and biological substances causing adverse effects in therapeutic use
- Complications of medical and surgical care
- External causes of morbidity and mortality
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 169 | 58 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | 47.88 | 45.69 | 54.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 249
- Matched controls
- 2490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y59
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances
16384.0
307.7
247
9
T78.4
ICD-10 Finland
Allergy, unspecified
22.6
108.1
91
62
C01CA24
ATC
epinephrine; parenteral
14.0
85.8
98
110
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
42.2
77.4
48
14
XQ800
NOMESCO Finland
Prick test
10.9
58.3
74
93
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.1
32.4
68
144
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
341.6
30.5
30
*
H02AB06
ATC
prednisolone; systemic
4.3
27.3
169
814
A92
ICPC
Allergy/allergic reaction NOS
7.5
21.4
33
50
R03DC03
ATC
montelukast; oral
3.9
20.8
83
286
T78.3
ICD-10 Finland
Angioneurotic oedema
25.1
19.5
27
12
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.3
18.2
55
154
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
17.4
18.0
28
18
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
16.3
78
297
J45.9
ICD-10 Finland
Asthma, unspecified
3.3
15.7
77
297
R4110
NOMESCO Finland
Physiotherapy
3.1
15.5
95
417
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
60.5
15.0
17
*
L50.9
ICD-10 Finland
Urticaria, unspecified
5.5
15.0
31
63
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
7.2
14.3
22
33
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.1
13.6
75
307
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
13.1
127
697
X58
ICD-10 Finland
Exposure to other specified factors
3.1
13.1
66
256
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.3
12.7
27
56
R03AC02
ATC
salbutamol; inhalant
2.8
12.5
180
1192
R03BB04
ATC
tiotropium bromide; inhalant
4.4
12.5
34
87
R06AE07
ATC
cetirizine; oral
2.6
12.4
145
865
J46
ICD-10 Finland
Status asthmaticus
10.1
12.3
24
26
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.0
11.8
37
105
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
11.7
53
192
WX892
NOMESCO Finland
Monitored bed care
4.3
11.7
32
82
R42
ICD-10 Finland
Dizziness and giddiness
2.9
11.7
70
298
R02
ICPC
Shortness of breath/dyspnoea
3.3
11.6
52
187
R06.0
ICD-10 Finland
Dyspnoea
2.7
11.6
87
416
Z3226
NOMESCO Finland
Physiotherapist
3.0
11.5
62
249
R06AX13
ATC
loratadine; oral
3.0
11.3
61
245
Z3231
NOMESCO Finland
Registered nurse
2.6
11.2
88
429
J01FF01
ATC
clindamycin; systemic
2.6
11.2
88
430
R06AX27
ATC
desloratadine; oral
2.5
11.0
110
601
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.0
10.7
24
52
H02AB07
ATC
prednisone; oral
3.3
10.6
45
156
E000001, ,
ATC
2.7
10.6
70
312
T88.1
ICD-10 Finland
Other complications following immunization, not elsewhere classified
114.6
10.5
11
*
Z2221
NOMESCO Finland
Medical doctor
2.5
10.1
94
493
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
10.1
107
595
XF600
NOMESCO Finland
Bloodpressure measurement
4.3
10.1
27
68
R03BA08
ATC
ciclesonide; inhalant
3.4
10.0
39
128
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
9.6
46
171
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
9.3
122
738
J45
ICD-10 Finland
Asthma
3.2
9.2
40
141
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
8.8
35
116
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.1
8.8
25
66
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
17.0
8.6
13
8
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.5
8.5
62
287
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
9.0
8.5
17
20
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
8.4
52
222
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
8.4
77
397
W00
ICD-10 Finland
Fall on same level involving ice and snow
3.1
8.4
38
137
D06
ICPC
Abdominal pain localized other
3.0
8.3
39
143
R03BA02
ATC
budesonide; inhalant
2.5
8.3
63
297
J45.1
ICD-10 Finland
Nonallergic asthma
3.4
8.3
32
104
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
8.3
79
413
R03AK08
ATC
formoterol and beclometasone; inhalant
4.0
8.3
24
64
Z2446
NOMESCO Finland
Social worker
3.5
8.2
30
94
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
8.1
63
301
L50.0
ICD-10 Finland
Allergic urticaria
6.5
8.0
20
33
X57
ICD-10 Finland
Unspecified privation
8.2
8.0
17
22
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
8.0
44
177
N17
ICPC
Vertigo/dizziness
2.8
7.9
43
171
S01GX01
ATC
cromoglicic acid; ophthalmic
2.4
7.9
71
361
N03AX16
ATC
[U] pregabalin
2.4
7.6
64
315
R03AC03
ATC
terbutaline; inhalant
2.7
7.6
46
194
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
7.5
35
128
A02BA02
ATC
ranitidine; systemic
2.6
7.5
49
215
G90.8
ICD-10 Finland
Other disorders of autonomic nervous system
82.4
7.5
8
*
XW000
NOMESCO Finland
Bone marrow biopsy
7.2
7.4
17
25
N06AX26
ATC
vortioxetine; oral
3.0
7.4
34
123
J01AA02
ATC
doxycycline; systemic
2.4
7.4
196
1514
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
7.4
30
101
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
7.4
38
147
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.6
7.4
50
223
B34.9
ICD-10 Finland
Viral infection, unspecified
4.7
7.3
17
38
ZXE00
NOMESCO Finland
One hour or less
2.1
7.2
112
704
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.5
7.2
25
76
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.6
7.2
24
71
L28
ICPC
Limited function/disability (L)
2.6
7.1
48
213
R60.0
ICD-10 Finland
Localized oedema
2.8
7.1
37
144
N02AX02
ATC
tramadol; systemic, rectal
2.1
7.1
110
691
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
7.1
90
525
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
7.0
24
72
R06AX26
ATC
fexofenadine; oral
3.1
7.0
30
104
C07AB07
ATC
bisoprolol; oral
2.1
7.0
107
668
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
6.9
25
78
J01FA06
ATC
roxithromycin; oral
2.0
6.8
106
665
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
6.8
39
160
R01AD58
ATC
fluticasone, combinations; nasal
2.1
6.8
86
500
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
6.7
32
118
AA1AD
NOMESCO Finland
CT of head and brain
2.2
6.7
68
361
E0000UV, ,
ATC
2.0
6.7
119
780
A02BC02
ATC
pantoprazole; systemic
2.1
6.7
170
1265
U02
ICPC
Urinary frequency/urgency
2.5
6.6
48
220
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
6.6
43
187
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.6
6.6
22
65
A02BC05
ATC
esomeprazole; systemic
2.0
6.6
107
679
Z50.1
ICD-10 Finland
Other physical therapy
4.0
6.5
19
51
ZXA00
NOMESCO Finland
Right side
2.2
6.4
62
322
R03BA05
ATC
fluticasone; inhalant
2.2
6.4
62
323
Z51.6
ICD-10 Finland
Desensitization to allergens
9.6
6.4
12
13
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
11.4
6.4
11
10
WX402
NOMESCO Finland
General anaesthesia
2.2
6.3
68
369
Y34
ICD-10 Finland
Unspecified event, undetermined intent
27.4
6.3
8
*
XF402
NOMESCO Finland
ECG with work load test
3.1
6.2
26
89
R96
ICPC
Asthma
2.7
6.2
34
136
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
6.1
45
208
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
6.1
64
344
R00.2
ICD-10 Finland
Palpitations
2.8
6.1
33
131
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
6.1
43
195
R01AD05
ATC
budesonide; nasal
3.0
6.1
27
96
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.0
95
592
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
187
1288
2.81
11.55
14.9
9.7
3.87
4.06
e9/l
0.71
164
1128
47
162
3.34
11.24
2.0
1.4
—
—
—
0
0
78
358
2.72
11.22
4.8
2.9
184.43
260.06
ng/l
0.21
47
232
134
833
2.32
9.64
2.2
2.0
102.13
97.51
pmol/l
0.51
78
435
30
86
3.83
9.40
1.4
1.7
0.24
0.23
g/l
0.48
30
86
35
112
3.47
9.34
3.2
3.2
24.25
24.22
mmol/l
0.02
35
112
136
859
2.29
9.32
8.7
6.5
1.22
1.22
mmol/l
0.00
130
803
95
516
2.36
9.30
4.0
1.8
0.98
1.14
mg/l
0.17
72
401
45
169
3.03
9.26
3.5
4.5
1.76
1.51
mmol/l
0.19
38
141
27
73
4.03
9.16
1.3
1.2
1.05
1.54
u/ml
0.25
17
40
39
137
3.19
8.97
2.5
1.5
—
—
—
0
0
101
575
2.27
8.76
3.1
2.2
2.77
2.81
mg/l
0.06
92
506
145
960
2.22
8.62
9.5
7.3
1.22
1.22
mmol/l
0.74
132
832
132
843
2.20
8.57
8.7
4.9
36.38
36.62
g/l
0.20
124
811
57
254
2.61
8.48
5.5
2.9
3.89
7.49
umol/l
1.90
51
223
64
316
2.38
7.59
2.6
1.9
—
—
—
0
0
93
541
2.15
7.41
1.8
1.6
17.45
22.06
nmol/l
2.60
81
470
27
86
3.40
7.23
1.9
1.4
—
—
—
0
0
51
232
2.51
7.20
2.4
1.7
—
—
—
0
0
50
226
2.52
7.15
2.4
1.8
—
—
—
0
0
20
52
4.09
7.13
14.6
5.1
317.33
849.00
iu/ml
—
6
6
13
13
10.48
7.12
1.7
1.4
—
—
—
0
0
46
207
2.50
6.62
2.8
2.3
29.89
29.75
u/l
0.01
35
163
11
10
11.44
6.36
1.4
4.0
1390.00
737.30
u/ml
—
11
10
45
208
2.42
6.10
11.1
4.4
236.42
249.48
u/l
0.23
45
199
62
329
2.18
6.09
3.7
3.0
2.19
3.45
e6/l
0.64
33
157
48
231
2.34
5.94
8.1
7.2
105.56
104.17
mmol/l
1.66
48
231
202
1637
2.24
5.92
5.5
4.2
12.08
9.85
mm/h
1.52
195
1530
65
355
2.12
5.92
3.8
2.7
0.31
0.89
e6/l
3.05
35
180
33
133
2.71
5.91
8.2
8.7
5.92
7.75
mmol/l
2.42
33
128
20
60
3.54
5.86
1.2
1.1
2.63
2.39
u/ml
0.04
13
31
160
1200
1.93
5.73
7.2
4.8
6.57
6.38
mmol/l
0.54
147
1111
137
981
1.88
5.62
3.1
2.6
76.54
75.59
nmol/l
0.14
127
903
19
57
3.53
5.56
1.5
1.2
—
—
—
0
0
163
1239
1.91
5.50
5.0
3.4
110.24
78.77
ug/l
0.53
157
1175
84
521
1.92
5.30
3.6
2.2
—
—
—
0
0
15
40
3.93
5.17
1.7
1.4
—
—
—
0
0
15
40
3.93
5.17
1.7
1.4
—
—
—
0
0
18
55
3.45
5.13
1.1
1.1
3.10
11.85
u/ml
1.23
13
25
81
502
1.91
5.10
4.4
2.7
317.64
319.68
umol/l
0.07
75
453
91
587
1.87
5.06
4.4
3.0
0.21
0.31
e6/l
0.70
73
417
74
455
1.89
4.72
3.1
3.0
386.52
798.53
ng/l
4.00
66
369
16
48
3.49
4.69
1.8
1.1
2.22
3.17
u/ml
—
9
18
16
48
3.49
4.69
2.0
3.1
0.50
1.41
index
—
8
27
16
48
3.49
4.69
1.2
1.1
—
—
—
0
0
178
1428
1.86
4.67
6.9
4.5
327.71
2508.58
e6/l
—
7
24
96
645
1.79
4.59
2.0
1.7
—
—
—
0
0
54
301
2.01
4.57
2.4
2.4
20.82
23.57
%
0.76
48
283
17
55
3.24
4.45
1.2
1.1
14.03
4.61
u/ml
0.74
12
30
18
61
3.10
4.38
1.1
1.2
2.83
31.51
e6/l
1.39
12
47
20
73
2.89
4.30
1.3
1.2
—
70.13
—
0
9
15
47
3.33
4.13
1.8
1.1
1.67
1.38
u/ml
—
6
16
17
60
2.97
3.87
1.1
1.0
1.40
16.11
e6/l
—
10
44
12
28
4.45
3.87
1.3
1.1
—
—
—
0
0
14
38
3.84
3.86
1.5
1.4
—
—
—
0
0
7
8
8.96
3.79
1.9
4.1
187.71
108.12
%
—
7
8
12
29
4.29
3.76
1.3
1.1
—
—
—
0
0
12
29
4.29
3.76
1.3
1.1
—
—
—
0
0
13
34
3.98
3.75
1.2
1.1
—
—
—
0
0
138
1069
1.65
3.70
3.8
2.8
—
—
estimate
—
0
0
24
105
2.42
3.66
1.8
1.7
—
—
—
0
0
14
46
3.17
3.59
1.1
1.1
0.12
0.40
u/ml
—
9
16
13
36
3.75
3.55
1.4
1.1
—
—
—
0
0
9
17
5.45
3.54
1.2
1.0
—
—
—
0
0
12
31
4.01
3.54
1.3
1.1
—
—
—
0
0
204
1773
1.83
3.37
6.2
4.7
14.60
14.51
pmol/l
0.22
193
1660
195
1675
1.76
3.33
5.3
3.7
—
—
—
0
0
11
28
4.06
3.33
1.3
1.1
—
—
—
0
0
21
91
2.43
3.27
1.1
1.4
—
—
—
0
0
97
707
1.61
3.20
3.5
3.2
36.99
37.39
ng/l
0.01
55
405
58
372
1.73
3.11
3.3
2.5
2.43
2.43
mmol/l
0.03
52
328
96
702
1.60
3.10
3.4
3.0
2.35
2.35
mmol/l
0.13
87
650
17
69
2.57
3.03
2.5
1.7
—
—
—
0
0
11
31
3.66
3.03
1.1
1.1
—
—
—
0
0
71
487
1.64
2.96
1.5
1.3
13.32
25.96
iu/ml
1.69
16
150
11
32
3.55
2.94
1.1
1.1
—
—
—
0
0
33
181
1.95
2.91
3.0
2.3
15.76
18.74
au/ml
—
5
15
236
2186
2.52
2.84
29.4
13.2
17.81
20.96
mg/l
1.05
214
1753
66
449
1.64
2.83
1.4
1.3
2.37
8.86
u/ml
2.12
15
178
10
28
3.68
2.81
1.1
1.1
—
—
—
0
0
5
6
8.47
2.76
4.0
4.0
0.66
0.62
mmol/l
—
5
6
8
19
4.31
2.70
1.4
1.0
—
—
—
0
0
7
15
4.77
2.61
2.0
1.1
—
—
—
0
0
21
103
2.13
2.50
1.7
1.6
—
—
—
0
0
19
91
2.18
2.40
3.1
2.6
0.74
0.63
%
0.78
19
91
5
8
6.35
2.38
1.0
1.0
—
—
—
0
0
7
17
4.20
2.37
1.0
1.1
—
—
—
0
0
144
1198
1.48
2.37
4.0
3.8
0.00
6.08
estimate
0.50
20
267
43
275
1.68
2.32
1.7
1.7
1268.03
1188.60
nmol/l
0.19
34
213
12
47
2.63
2.30
1.5
1.9
—
—
—
0
0
19
93
2.13
2.28
3.1
2.7
1.23
1.25
%
0.04
19
93
14
60
2.41
2.26
1.6
1.4
360.45
268.53
u/ml
—
9
33
14
60
2.41
2.26
1.2
1.3
350.43
331.22
ug/g
—
7
33
24
129
1.95
2.26
9.5
9.1
25.83
24.86
mmol/l
0.62
24
129
144
1208
1.46
2.21
4.2
3.8
0.00
0.00
estimate
-0.00
19
254
142
1189
1.45
2.19
4.0
3.7
0.00
0.00
estimate
0.50
20
269
14
61
2.37
2.19
1.9
1.7
—
—
—
0
0
222
2045
1.79
2.17
22.4
11.9
91.74
89.47
ml/min/173m2
0.89
213
1873
37
232
1.70
2.15
1.3
1.3
160.21
131.94
u/ml
0.14
19
92
11
43
2.63
2.11
1.8
1.5
—
—
—
0
0
6
15
4.07
2.05
1.3
1.1
8.83
10.40
mm/h
—
6
15
11
44
2.57
2.04
1.3
1.1
—
—
—
0
0
8
27
3.03
1.95
2.9
1.9
—
—
—
0
0
86
670
1.43
1.90
1.5
1.3
1.32
1.54
u/ml
0.11
13
188
17
86
2.05
1.90
1.4
1.2
—
1.60
—
0
11
32
201
1.68
1.86
1.9
2.4
27851.77
5401.06
u/l
—
9
91
221
2053
1.68
1.83
7.6
5.6
1.69
1.80
mu/l
0.99
216
1938
7
23
3.10
1.81
3.1
2.0
—
—
—
0
0
13
60
2.23
1.81
1.2
1.4
—
—
—
0
0
177
1576
1.43
1.75
5.6
3.2
44.51
40.00
u/l
0.33
171
1508
5
13
3.90
1.72
1.0
1.1
—
—
—
0
0
109
899
1.38
1.70
2.0
1.9
1.48
1.37
mmol/l
0.48
97
772
17
90
1.95
1.70
1.2
1.3
—
—
—
0
0
7
25
2.85
1.66
1.4
1.4
—
—
—
0
0
10
43
2.38
1.61
2.7
1.7
—
—
—
0
0
12
57
2.16
1.57
1.3
1.3
201.67
176.83
au/ml
—
6
15
238
2276
2.03
1.52
19.4
10.5
27.12
25.29
u/l
0.98
233
2226
22
133
1.72
1.48
1.5
1.4
169.17
290.55
miu/ml
1.03
13
65
9
38
2.42
1.47
1.0
1.1
—
10.88
—
0
8
7
28
2.54
1.46
1.4
1.2
—
—
—
0
0
13
66
2.02
1.46
1.5
1.2
—
1.10
—
0
6
12
59
2.09
1.46
1.3
1.3
—
—
—
0
0
13
67
1.99
1.41
2.5
1.7
—
—
—
0
0
9
41
2.24
1.38
2.6
1.5
—
—
—
0
0
5
17
2.98
1.36
1.4
1.2
145.20
103.53
pmol/l
—
5
17
6
24
2.54
1.31
1.2
1.0
—
—
—
0
0
15
84
1.84
1.30
4.5
5.3
61.01
46.84
%
1.20
15
84
12
62
1.98
1.30
1.3
1.5
—
—
—
0
0
11
55
2.05
1.29
6.1
4.3
22.85
24.51
mmol/l
0.99
11
55
5
18
2.81
1.29
1.2
1.5
—
—
—
0
0
206
1924
1.41
1.24
35.7
17.1
332.12
332.41
g/l
0.18
206
1914
7
30
2.37
1.13
2.1
1.7
—
—
—
0
0
28
194
1.50
1.13
1.5
1.4
18.20
22.22
iu/l
0.36
23
170
7
34
2.09
1.03
1.1
1.1
—
—
—
0
0
10
53
1.92
1.03
2.2
1.7
—
—
—
0
0
6
27
2.25
0.94
2.5
1.9
—
—
—
0
0
11
63
1.78
0.91
7.1
8.5
9.02
8.46
kpa
0.56
11
63
5
104
0.47
0.91
1.2
1.6
73.14
51.39
ug/l
—
5
104
7
126
0.54
0.91
3.1
1.5
—
—
—
0
0
210
1994
1.34
0.90
4.9
4.3
5.85
5.72
mmol/l
0.62
202
1867
6
29
2.09
0.90
1.0
1.2
—
—
—
0
0
26
187
1.44
0.89
3.0
3.2
—
—
—
0
0
244
2394
1.96
0.80
39.7
20.5
90.22
90.22
fl
0.01
244
2378
21
150
1.44
0.76
2.0
3.1
76.00
76.92
ml/min/173m2
0.05
11
60
5
24
2.10
0.75
1.2
1.5
—
—
—
0
0
6
108
0.54
0.74
1.0
1.1
1.25
1.57
g/l
—
6
108
7
39
1.82
0.73
1.1
1.2
—
—
—
0
0
5
26
1.94
0.71
1.4
1.3
—
—
—
0
0
7
120
0.57
0.69
1.6
1.8
—
—
—
0
0
244
2396
1.91
0.68
40.2
20.6
133.11
134.79
g/l
1.11
244
2378
63
542
1.22
0.64
3.5
4.1
23.20
41.33
mg/mmol
0.21
41
336
5
29
1.74
0.64
2.6
2.3
17.74
16.08
%
—
5
29
34
272
1.29
0.64
2.0
2.0
—
—
—
0
0
8
51
1.59
0.61
2.4
1.7
—
—
—
0
0
12
81
1.51
0.58
1.2
1.2
—
—
—
0
0
6
36
1.68
0.57
1.3
1.1
—
—
—
0
0
40
332
1.24
0.57
2.3
2.1
—
—
—
0
0
13
182
0.70
0.56
1.4
1.5
—
—
—
0
0
9
60
1.52
0.55
3.1
2.3
—
—
—
0
0
6
38
1.59
0.54
1.7
2.5
3.80
6.21
u/ml
—
6
38
6
39
1.55
0.53
3.0
1.8
—
—
—
0
0
9
65
1.40
0.51
2.6
1.8
—
—
—
0
0
7
109
0.63
0.49
2.0
1.1
0.83
0.83
g/l
—
7
109
7
45
1.57
0.49
7.0
4.0
16.54
22.97
mg/l
—
7
39
7
45
1.57
0.49
6.9
4.0
82.31
37.06
mg/l
—
7
39
10
68
1.49
0.47
3.5
1.9
—
—
—
0
0
10
68
1.49
0.47
2.4
1.8
0.30
1.05
ug/l
—
10
63
15
195
0.75
0.43
10.4
6.1
—
—
—
0
0
5
32
1.57
0.42
2.2
1.7
—
—
—
0
0
8
59
1.37
0.41
1.6
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
129.42
—
0
17
5
34
1.48
0.40
1.2
1.1
13.05
21.54
u/l
—
5
29
5
34
1.48
0.40
3.2
2.1
13.40
13.24
%
—
5
34
11
80
1.39
0.39
1.5
3.3
4.32
5.74
umol/l
—
6
60
61
552
1.14
0.35
1.6
1.6
—
—
—
0
0
199
1933
1.15
0.34
6.0
5.4
38.38
37.90
mmol/mol
0.28
191
1834
12
154
0.77
0.33
1.5
2.6
25.78
37.00
u/ml
0.46
12
148
20
165
1.23
0.32
1.1
1.0
—
—
—
0
0
7
54
1.30
0.30
1.0
1.2
—
—
—
0
0
10
76
1.33
0.28
2.6
5.3
1.13
1.25
mg/l
—
10
69
11
139
0.78
0.27
1.3
1.7
—
—
—
0
0
15
125
1.21
0.23
1.7
1.4
0.57
0.28
mg/l
—
9
49
5
40
1.26
0.22
1.2
2.9
8.16
8.13
pmol/l
—
5
40
8
105
0.75
0.21
1.4
2.2
—
—
—
0
0
207
2099
0.92
0.16
5.0
4.5
4.61
4.71
mmol/l
0.90
200
1994
9
80
1.13
0.15
1.3
1.2
—
—
—
0
0
18
202
0.88
0.15
2.6
2.8
0.80
0.82
ug/l
0.04
12
114
207
2096
0.93
0.13
4.9
4.4
1.45
1.49
mmol/l
0.68
197
1981
69
715
0.95
0.10
4.1
2.9
0.00
0.01
estimate
0.74
17
209
55
527
1.06
0.10
3.9
3.8
1.02
1.02
kg/l
0.19
26
363
25
266
0.93
0.08
2.6
4.2
23.35
22.92
%
—
10
125
89
910
0.97
0.07
4.1
3.5
0.00
0.02
estimate
0.68
16
220
213
2117
1.04
0.05
5.4
4.9
2.74
2.79
mmol/l
0.37
204
2010
12
111
1.09
0.04
1.3
1.4
—
—
—
0
0
53
518
1.03
0.03
3.2
2.3
—
—
—
0
0
16
152
1.06
0.02
2.1
1.4
—
—
—
0
0
16
152
1.06
0.02
1.2
1.5
—
—
—
0
0
48
471
1.02
0.02
3.2
2.1
—
—
—
0
0
16
153
1.05
0.01
1.2
1.5
0.81
1.16
ratio
—
10
95
16
153
1.05
0.01
1.2
1.5
0.90
0.96
ratio
—
10
95
16
153
1.05
0.01
1.2
1.5
0.65
1.09
ratio
—
10
95
199
1996
0.99
0.00
4.2
3.8
1.34
1.24
mmol/l
1.13
191
1874
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.2
1.79
3.11
ug/l
—
6
58
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
65
650
1.00
-0.00
3.8
3.8
0.00
0.00
estimate
0.50
19
257
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
12.15
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
0.58
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST – Other and unspecified vaccines and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).